Qian LI, Jian-jun LIU. The value of18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J]. Int J Radiat Med Nucl Med, 2011, 35(4): 220-222. DOI: 10.3760/cma.j.issn.1673-4114.2011.04.006
Citation:
Qian LI, Jian-jun LIU. The value of18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J]. Int J Radiat Med Nucl Med, 2011, 35(4): 220-222. DOI: 10.3760/cma.j.issn.1673-4114.2011.04.006
Qian LI, Jian-jun LIU. The value of18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J]. Int J Radiat Med Nucl Med, 2011, 35(4): 220-222. DOI: 10.3760/cma.j.issn.1673-4114.2011.04.006
Citation:
Qian LI, Jian-jun LIU. The value of18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J]. Int J Radiat Med Nucl Med, 2011, 35(4): 220-222. DOI: 10.3760/cma.j.issn.1673-4114.2011.04.006
The value of18F-FDG PET-CT in lymphoma therapy evaluation and prognosis
18F-FDG PET-CT as a molecular imaging technology for velocity rate and quantity of FDG has become a standard imaging technique for staging and follow-up of lymphoma.However, its value in therapy evaluation and prognosis is not very clear.This article summarizes some related papers in recent years and reviews its value in therapy evaluation and prognosis of lymphoma.
DownLoad: